Advertisement
Hospitals that volunteered to be under financial incentives for more than a decade as part of the Premier Hospital Quality Incentive Demonstration do not have better process scores or lower mortality than hospitals where these incentives were implemented later under the Hospital Value-Based Purchasing program

For Hospitals, No Benefit for Early Adoption of Financial Incentives

0
Hospitals with early adoption do not have better process scores, lower mortality than late adopters
In both men and women in the United States

Cancer Death Rate Continuing to Decline in United States

0
Continuous drop in combined cancer death rate from 1991 to 2015, resulting in 2,378,600 fewer deaths
Although patients with pre-existing autoimmune disease who receive checkpoint inhibitors (CPIs) are at risk for exacerbation of their disease

Immune-Related Adverse Events Up With Checkpoint Inhibitors

0
Most patients with cancer, autoimmune disease have improvement in events without discontinuing therapy
Racial/ethnic disparities in the receipt of live donor kidney transplantation among first-time kidney transplantation candidates in the United States increased from 1995-1999 to 2010-2014

Racial/Ethnic Disparities Up for Live Donor Kidney Transplant

0
Compared to 1995 to 1999, increase in racial/ethnic disparities in receipt of LDKT in 2010 to 2014

December 2017 Briefing – Nephrology

0
Here are what the editors at HealthDay consider to be the most important developments in Nephrology for December 2017. This roundup includes the latest...
Across cancers

Out-of-Pocket Costs Correlate With Receipt of Cancer Care

0
Across cancers, higher costs tied to higher rates of oral prescription abandonment, delayed initiation
The cumulative risk of end-stage renal disease among patients with type 1 diabetes has declined over time in Finland

Risk of ESRD in T1DM Patients Has Fallen Markedly in Finland

0
Relative risk of end-stage renal disease was 0.13 in those diagnosed in 1995-2011 versus 1965-1979
Rituximab treatment seems effective for systemic lupus erythematosus-associated immune cytopenias

Rituximab Effective for Lupus-Associated Cytopenia

0
Overall initial response rate of 86 percent in 71 patients, with complete response for 60.5 percent
From 2015 to 2016

CDC: 2015 to 2016 Saw Drop in Life Expectancy in United States

0
Increase in rate of age-adjusted drug overdose deaths observed during same time period
In their first year

Early-Stage Cancer Diagnoses Up With ACA’s Medicaid Expansions

0
Both overall and early diagnosis of cancer increased in first year of expansions